Shares of Amneal Pharmaceuticals Inc. (AMRX) touched a new high of $9.62 yesterday, driven by its recent strong quarterly performance and an upward revision to full-year 2025 guidance.
This global pharmaceutical company develops, manufactures, markets, and distributes a diverse portfolio of essential medicines, including retail generics, injectables, biosimilars, and specialty branded pharmaceuticals. It has three reportable segments - Generics, Specialty, and AvKARE.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.